Abstract
It is essential, in order to minimize expensive drug failures, to determine potential toxicity problems as early as possible. In view of the large libraries of compounds now being handled by combinatorial chemistry and high-throughput screening, identification of drug toxicity is advisable even before synthesis. Thus, the use of predictive toxicology is called for. A great number of in silico approaches to toxicity prediction have been described in the literature, but one of the most ambitious goals of QSAR applications to toxicology is modeling of chemical carcinogenicity, which has severe consequences on the quality of life and has led to enormous investments in time, financial resources, and animal lives necessary to test the chemicals adequately. This review attempts to summarize present knowledge related to the computational prediction of carcinogenicity. Several computational protocols are described, ranging from knowledge-based approaches and statistically-based systems to simple and fast procedures based on only the 2-D graphing of the investigated structures. Comparative tests of the ability of these systems to predict carcinogenicity show that improvement is still needed. The consensus approach is recommended, whereby the results from several prediction systems are pooled.
Keywords: carcinogenesis, qsar, aromatic amines, pahs, expert systems
Current Computer-Aided Drug Design
Title: The Prediction of Carcinogenicity from Molecular Structure
Volume: 1 Issue: 3
Author(s): Aliuska Morales Helguera, Miguel Angel Cabrera Perez, Robert D. Combes and Maykel Perez Gonzalez
Affiliation:
Keywords: carcinogenesis, qsar, aromatic amines, pahs, expert systems
Abstract: It is essential, in order to minimize expensive drug failures, to determine potential toxicity problems as early as possible. In view of the large libraries of compounds now being handled by combinatorial chemistry and high-throughput screening, identification of drug toxicity is advisable even before synthesis. Thus, the use of predictive toxicology is called for. A great number of in silico approaches to toxicity prediction have been described in the literature, but one of the most ambitious goals of QSAR applications to toxicology is modeling of chemical carcinogenicity, which has severe consequences on the quality of life and has led to enormous investments in time, financial resources, and animal lives necessary to test the chemicals adequately. This review attempts to summarize present knowledge related to the computational prediction of carcinogenicity. Several computational protocols are described, ranging from knowledge-based approaches and statistically-based systems to simple and fast procedures based on only the 2-D graphing of the investigated structures. Comparative tests of the ability of these systems to predict carcinogenicity show that improvement is still needed. The consensus approach is recommended, whereby the results from several prediction systems are pooled.
Export Options
About this article
Cite this article as:
Helguera Morales Aliuska, Perez Angel Cabrera Miguel, Combes D. Robert and Gonzalez Perez Maykel, The Prediction of Carcinogenicity from Molecular Structure, Current Computer-Aided Drug Design 2005; 1 (3) . https://dx.doi.org/10.2174/1573409054367655
DOI https://dx.doi.org/10.2174/1573409054367655 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Antitumor Effects of Britanin on Hepatocellular Carcinoma Cells and its Real-Time Evaluation by In Vivo Bioluminescence Imaging
Anti-Cancer Agents in Medicinal Chemistry Cancer Stem Cell Model in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy Expression Microarray Proteomics and the Search for Cancer Biomarkers
Current Genomics Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance
Anti-Cancer Agents in Medicinal Chemistry Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship
Reviews on Recent Clinical Trials Flavonoids in Atherosclerosis: An Overview of Their Mechanisms of Action
Current Medicinal Chemistry SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Current Pharmaceutical Design Preclinical and Clinical Studies of Novel Breast Cancer Drugs Targeting Molecules Involved in Protein Kinase C Signaling, the Putative Metastasis-Suppressor Gene Cap43 and the Y-box Binding Protein-1
Current Medicinal Chemistry Recent Advances in Pharmacological Interventions of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome
Current Pharmaceutical Design Anti-cancer and Anti-angiogenic Properties of Various Natural Pentacyclic Tri-terpenoids and Some of their Chemical Derivatives
Current Organic Chemistry Renal Development: A Complex Process Dependent on Inductive Interaction
Current Pediatric Reviews Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Anti-Cancer Agents in Medicinal Chemistry Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates
Current Topics in Medicinal Chemistry A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency
Endocrine, Metabolic & Immune Disorders - Drug Targets Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis
Current Topics in Medicinal Chemistry The Prevention of Oral Mucositis in Patients with Blood Cancers: Current Concepts and Emerging Landscapes
Cardiovascular & Hematological Agents in Medicinal Chemistry Synthesis and Applications of Nanoflowers
Recent Patents on Nanotechnology Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far
Recent Patents on Anti-Cancer Drug Discovery Analytical Methods for the Quantification of Cisplatin, Carboplatin, and Oxaliplatin in Various Matrices over the Last Two Decades
Current Pharmaceutical Analysis